Zobrazeno 1 - 10
of 441
pro vyhledávání: '"Price, RN"'
Autor:
Monica Parry, NP-Adult, PhD, Ann Kristin Bjørnnes, RN, CNM, MSc, PhD, Margaret Harrington, BKin, Michelle Duong, BScN, Salma El Ali, BA (student), Arland O’Hara, BSc, Hance Clarke, MD, PhD, FRCPC, Lynn Cooper, BSc, Donna Hart, BA, Paula Harvey, BMBS, PhD, FRACP, Chitra Lalloo, BHSc, PhD, Judith McFetridge-Durdle, RN, PhD, Michael H. McGillion, RN, PhD, Colleen Norris, PhD, GNP, MSc, BScN, RN-FAHA, Louise Pilote, MD, MPH, PhD, Jennifer Price, RN, PhD, Jennifer Stinson, RN-EC, PhD, CPNP, Judy Watt-Watson, RN, MSc, PhD
Publikováno v:
CJC Open, Vol 4, Iss 2, Pp 214-222 (2022)
Background: Women with physical disabilities are faced with challenges in many aspects of life—education, work, income, relationships, as well as their general health. These women are at a greater risk of developing heart disease. This study aimed
Externí odkaz:
https://doaj.org/article/cd6714ff2feb43bd97cb46ee7b38dd7b
Autor:
Thriemer, K, Degaga, TS, Alam, MS, Adhikari, B, Tripura, R, Hossain, MS, Christian, M, Ghanchi, NK, Mnjala, H, Weston, S, Ley, B, Rumaseb, A, Tadesse, D, Teferi, T, Yilma, D, Lee, G, Unger, H, Sutanto, I, Pasaribu, AP, Ghimire, P, Beg, MA, Price, RN
Background: The COVID-19 pandemic and resulting restrictions, particularly travel restrictions, have had significant impact on the conduct of global clinical trials. Our clinical trials programme, which relied on in-person visits for training, monito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd9bc1571216e34cc833f456f4d30267
https://doi.org/10.1177/17407745231154215
https://doi.org/10.1177/17407745231154215
Autor:
Leonardo, L, Kenangalem, E, Poespoprodjo, JR, Noviyanti, R, Price, RN, Anstey, NM, Minigo, G, Kho, S
Publikováno v:
Malaria Journal. 21
Background Circulating myeloid-derived-suppressor-cells (MDSC) with immunosuppressive function are increased in human experimental Plasmodium falciparum infection, but have not been studied in clinical malaria. Methods Using flow-cytometry, circulati
Autor:
Ley, B, Satyagraha, AW, Kibria, MG, Armstrong, J, Bizij, G, Bancone, G, Wojnarski, M, Bei, AK, Brito, M, Domingo, G, Ding, X, von Fricken, M, Gornsawun, G, Lam, B, Menard, D, Pal, S, Parikh, S, Panggalo, LV, Pfeffer, D, Price, RN, Orfano, ADS, Wade, M, Worachet, K, Monteiro, W, Yar, A, Alam, MS, Howes, RE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::487ab6a1cc8f9900e0630187ca49e3a9
https://doi.org/10.4269/ajtmh.abstract2021
https://doi.org/10.4269/ajtmh.abstract2021
Autor:
Studniberg, SI, Ioannidis, LJ, Utami, RAS, Trianty, L, Liao, Y, Abeysekera, W, Li-Wai-Suen, CSN, Pietrzak, HM, Healer, J, Puspitasari, AM, Apriyanti, D, Coutrier, F, Poespoprodjo, JR, Kenangalem, E, Andries, B, Prayoga, P, Sariyanti, N, Smyth, GK, Cowman, AF, Price, RN, Noviyanti, R, Shi, W, Garnham, AL, Hansen, DS
Publikováno v:
Molecular Systems Biology. 18
Clinical immunity to P. falciparum malaria is non-sterilizing, with adults often experiencing asymptomatic infection. Historically, asymptomatic malaria has been viewed as beneficial and required to help maintain clinical immunity. Emerging views sug
Publikováno v:
BMC Research Notes. 15
Objective Glucose-6-phosphate dehydrogenase (G6PD) deficiency offers some protection against malaria; however, the degree of protection is poorly described and likely to vary with G6PD genotype and Plasmodium species. We present a novel approach to q
Autor:
Watson, JA, Commons, RJ, Tarning, J, Simpson, JA, Llanos Cuentas, A, Lacerda, MVG, Green, JA, Koh, GCKW, Chu, CS, Nosten, FH, Price, RN, Day, NPJ, White, NJ
Tafenoquine is a newly licensed antimalarial drug for the radical cure of Plasmodium vivax malaria. The mechanism of action and optimal dosing are uncertain. We pooled individual data from 1102 patients and 72 healthy volunteers studied in the pre-re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::107a38001530d49ed2404bc8a1984537
https://hdl.handle.net/20.500.12866/13004
https://hdl.handle.net/20.500.12866/13004
Autor:
Ley, B, Alam, MS, Satyagraha, AW, Phru, CS, Thriemer, K, Tadesse, D, Shibiru, T, Hailu, A, Kibria, MG, Hossain, MS, Rahmat, H, Poespoprodjo, JR, Khan, WA, Simpson, JA, Price, RN
Publikováno v:
PLoS neglected tropical diseases. 16(5)
Primaquine and tafenoquine are the only licensed drugs with activity against Plasmodium vivax hypnozoites but cause haemolysis in patients with glucose–6–phosphate dehydrogenase (G6PD) deficiency. Malaria also causes haemolysis, leading to the re
Autor:
Pfeffer, DA, Satyagraha, AW, Sadhewa, A, Alam, MS, Bancone, G, Boum, Y, Brito, M, Cui, L, Deng, Z, Domingo, GJ, He, Y, Khan, WA, Kibria, MG, Lacerda, M, Menard, D, Monteiro, W, Pal, S, Parikh, S, Roca-Feltrer, A, Roh, M, Sirdah, MM, Wang, D, Huang, Q, Howes, RE, Price, RN, Ley, B
Publikováno v:
Pathogens
Pathogens, 2022, 11 (9), pp.1045. ⟨10.3390/pathogens11091045⟩
Pathogens, 2022, 11 (9), pp.1045. ⟨10.3390/pathogens11091045⟩
Low glucose-6-phosphate dehydrogenase enzyme (G6PD) activity is a key determinant of drug-induced haemolysis. More than 230 clinically relevant genetic variants have been described. We investigated the variation in G6PD activity within and between di